✦ LIBER ✦

Treatment-related mortality with vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy in patients with advanced solid tumors: A meta-analysis

✍ Scribed by Shanthi Sivendran; Ziyue Liu; Louis J. Portas Jr; Menggang Yu; Noah Hahn; Guru Sonpavde; William K. Oh; Matthew D. Galsky

Book ID: 119224510
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 298 KB
Volume: 38
Category: Article
ISSN: 0305-7372
DOI: 10.1016/j.ctrv.2012.05.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

137 A phase I study of an oral vascular

137 A phase I study of an oral vascular endothelial growth factor receptor-2 (VEGFR-2) tyrosine kinase inhibitor, CP-547,632, in patients with advanced solid tumors

✍ Tolcher, A.; O'Leary, J.J.; DeBono, J.; Molpus, K.; Woodard, C.; Warnat, M.; Lia 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Risk of bleeding with vascular endotheli

Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials

✍ Youjin Je; Fabio AB Schutz; Toni K Choueiri 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 223 KB

An Evaluation of the Drug Interaction Po

An Evaluation of the Drug Interaction Potential of Pazopanib, an Oral Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, Using a Modified Cooperstown 5+1 Cocktail in Patients With Advanced Solid Tumors

✍ Goh, B C; Reddy, N J; Dandamudi, U B; Laubscher, K H; Peckham, T; Hodge, J P; Su 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 291 KB

Risk of thyroid dysfunction in patients

Risk of thyroid dysfunction in patients with solid tumors treated with VEGF receptor tyrosine kinase inhibitors: a critical literature review and meta analysis

✍ Abdel-Rahman, Omar ;Fouad, Mona 📂 Article 📅 2014 🏛 Expert Reviews 🌐 English ⚖ 473 KB

Phase II Study of Cediranib, an Oral Pan

Phase II Study of Cediranib, an Oral Pan-Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma

✍ Batchelor, T. T.; Duda, D. G.; di Tomaso, E.; Ancukiewicz, M.; Plotkin, S. R.; G 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 107 KB

Phase I Clinical and Pharmacokinetic Stu

Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors

✍ Strumberg, D. 📂 Article 📅 2005 🏛 American Society of Clinical Oncology 🌐 English ⚖ 207 KB